LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 21

Search options

  1. Article: Feasibility and Safety of Bilateral Hybrid EEG/EOG Brain/Neural-Machine Interaction.

    Nann, Marius / Peekhaus, Niels / Angerhöfer, Cornelius / Soekadar, Surjo R

    Frontiers in human neuroscience

    2020  Volume 14, Page(s) 580105

    Abstract: Cervical spinal cord injuries (SCIs) often lead to loss of motor function in both hands and legs, limiting autonomy and quality of life. While it was shown that unilateral hand function can be restored after SCI using a hybrid electroencephalography/ ... ...

    Abstract Cervical spinal cord injuries (SCIs) often lead to loss of motor function in both hands and legs, limiting autonomy and quality of life. While it was shown that unilateral hand function can be restored after SCI using a hybrid electroencephalography/electrooculography (EEG/EOG) brain/neural hand exoskeleton (B/NHE), it remained unclear whether such hybrid paradigm also could be used for operating two hand exoskeletons, e.g., in the context of bimanual tasks such as eating with fork and knife. To test whether EEG/EOG signals allow for fluent and reliable as well as safe and user-friendly bilateral B/NHE control, eight healthy participants (six females, mean age 24.1 ± 3.2 years) as well as four chronic tetraplegics (four males, mean age 51.8 ± 15.2 years) performed a complex sequence of EEG-controlled bilateral grasping and EOG-controlled releasing motions of two exoskeletons visually presented on a screen. A novel EOG command performed by prolonged horizontal eye movements (>1 s) to the left or right was introduced as a reliable switch to activate either the left or right exoskeleton. Fluent EEG control was defined as average "time to initialize" (TTI) grasping motions below 3 s. Reliable EEG control was assumed when classification accuracy exceeded 80%. Safety was defined as "time to stop" (TTS) all unintended grasping motions within 2 s. After the experiment, tetraplegics were asked to rate the user-friendliness of bilateral B/NHE control using Likert scales. Average TTI and accuracy of EEG-controlled operations ranged at 2.14 ± 0.66 s and 85.89 ± 15.81% across healthy participants and at 1.90 ± 0.97 s and 81.25 ± 16.99% across tetraplegics. Except for one tetraplegic, all participants met the safety requirements. With 88 ± 11% of the maximum achievable score, tetraplegics rated the control paradigm as user-friendly and reliable. These results suggest that hybrid EEG/EOG B/NHE control of two assistive devices is feasible and safe, paving the way to test this paradigm in larger clinical trials performing bimanual tasks in everyday life environments.
    Language English
    Publishing date 2020-12-09
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2425477-0
    ISSN 1662-5161
    ISSN 1662-5161
    DOI 10.3389/fnhum.2020.580105
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Brain-Computer Interface-Controlled Exoskeletons in Clinical Neurorehabilitation: Ready or Not?

    Colucci, Annalisa / Vermehren, Mareike / Cavallo, Alessia / Angerhöfer, Cornelius / Peekhaus, Niels / Zollo, Loredana / Kim, Won-Seok / Paik, Nam-Jong / Soekadar, Surjo R

    Neurorehabilitation and neural repair

    2022  Volume 36, Issue 12, Page(s) 747–756

    Abstract: The development of brain-computer interface-controlled exoskeletons promises new treatment strategies for neurorehabilitation after stroke or spinal cord injury. By converting brain/neural activity into control signals of wearable actuators, brain/neural ...

    Abstract The development of brain-computer interface-controlled exoskeletons promises new treatment strategies for neurorehabilitation after stroke or spinal cord injury. By converting brain/neural activity into control signals of wearable actuators, brain/neural exoskeletons (B/NEs) enable the execution of movements despite impaired motor function. Beyond the use as assistive devices, it was shown that-upon repeated use over several weeks-B/NEs can trigger motor recovery, even in chronic paralysis. Recent development of lightweight robotic actuators, comfortable and portable real-world brain recordings, as well as reliable brain/neural control strategies have paved the way for B/NEs to enter clinical care. Although B/NEs are now technically ready for broader clinical use, their promotion will critically depend on early adopters, for example, research-oriented physiotherapists or clinicians who are open for innovation. Data collected by early adopters will further elucidate the underlying mechanisms of B/NE-triggered motor recovery and play a key role in increasing efficacy of personalized treatment strategies. Moreover, early adopters will provide indispensable feedback to the manufacturers necessary to further improve robustness, applicability, and adoption of B/NEs into existing therapy plans.
    MeSH term(s) Humans ; Exoskeleton Device ; Brain-Computer Interfaces ; Neurological Rehabilitation ; Brain ; Robotics
    Language English
    Publishing date 2022-11-25
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 1491637-x
    ISSN 1552-6844 ; 1545-9683 ; 0888-4390
    ISSN (online) 1552-6844
    ISSN 1545-9683 ; 0888-4390
    DOI 10.1177/15459683221138751
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response.

    Storey, Claire M / Altai, Mohamed / Bicak, Mesude / Veach, Darren R / Lückerath, Katharina / Adrian, Gabriel / McDevitt, Michael R / Kalidindi, Teja / Park, Julie E / Herrmann, Ken / Abou, Diane / Zedan, Wahed / Peekhaus, Norbert / Klein, Robert J / Damoiseaux, Robert / Larson, Steven M / Lilja, Hans / Thorek, Daniel / Ulmert, David

    Molecular cancer research : MCR

    2024  Volume 21, Issue 4, Page(s) 307–315

    Abstract: Noninvasive biomarkers for androgen receptor (AR) pathway activation are urgently needed to better monitor patient response to prostate cancer therapies. AR is a critical driver and mediator of resistance of prostate cancer but currently available ... ...

    Abstract Noninvasive biomarkers for androgen receptor (AR) pathway activation are urgently needed to better monitor patient response to prostate cancer therapies. AR is a critical driver and mediator of resistance of prostate cancer but currently available noninvasive prostate cancer biomarkers to monitor AR activity are discordant with downstream AR pathway activity. External beam radiotherapy (EBRT) remains a common treatment for all stages of prostate cancer, and DNA damage induced by EBRT upregulates AR pathway activity to promote therapeutic resistance. [89Zr]11B6-PET is a novel modality targeting prostate-specific protein human kallikrein 2 (hK2), which is a surrogate biomarker for AR activity. Here, we studied whether [89Zr]11B6-PET can accurately assess EBRT-induced AR activity.Genetic and human prostate cancer mouse models received EBRT (2-50 Gy) and treatment response was monitored by [89Zr]11B6-PET/CT. Radiotracer uptake and expression of AR and AR target genes was quantified in resected tissue.EBRT increased AR pathway activity and [89Zr]11B6 uptake in LNCaP-AR and 22RV1 tumors. EBRT increased prostate-specific [89Zr]11B6 uptake in prostate cancer-bearing mice (Hi-Myc x Pb_KLK2) with no significant changes in uptake in healthy (Pb_KLK2) mice, and this correlated with hK2 protein levels.
    Implications: hK2 expression in prostate cancer tissue is a proxy of EBRT-induced AR activity that can noninvasively be detected using [89Zr]11B6-PET; further clinical evaluation of hK2-PET for monitoring response and development of resistance to EBRT in real time is warranted.
    MeSH term(s) Animals ; Humans ; Male ; Mice ; Cell Line, Tumor ; Positron Emission Tomography Computed Tomography ; Prostatic Neoplasms/diagnostic imaging ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/radiotherapy ; Radioisotopes ; Receptors, Androgen/genetics ; Receptors, Androgen/metabolism ; Zirconium
    Chemical Substances Radioisotopes ; Receptors, Androgen ; Zirconium (C6V6S92N3C) ; Zirconium-89 (NTM296JU95)
    Language English
    Publishing date 2024-03-19
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2098788-2
    ISSN 1557-3125 ; 1541-7786
    ISSN (online) 1557-3125
    ISSN 1541-7786
    DOI 10.1158/1541-7786.MCR-22-0736
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Kinetics of Sugar Transport and Phosphorylation Influence Glucose and Fructose Cometabolism by Zymomonas mobilis.

    Parker, C / Peekhaus, N / Zhang, X / Conway, T

    Applied and environmental microbiology

    2006  Volume 63, Issue 9, Page(s) 3519–3525

    Abstract: The competitive inhibition of fructokinase by glucose has been proposed as the mechanism by which Zymomonas mobilis preferentially consumes glucose from mixtures of glucose and fructose and accumulates fructose when growing on sucrose. In this study, ... ...

    Abstract The competitive inhibition of fructokinase by glucose has been proposed as the mechanism by which Zymomonas mobilis preferentially consumes glucose from mixtures of glucose and fructose and accumulates fructose when growing on sucrose. In this study, incorporation of radioactive fructose into biomass was used as a measure of fructose catabolism. It was determined that the rate of fructose incorporation by Z. mobilis CP4 was somewhat lower in the presence of an equimolar concentration of glucose but that the inhibition of fructokinase by glucose was not nearly as severe in vivo as was predicted from in vitro studies. Interestingly, addition of glucose to a culture of Z. mobilis CP4-M2, a glucokinaseless mutant, resulted in an immediate and nearly complete inhibition of fructose incorporation. Furthermore, addition of nonmetabolizeable glucose analogs had a similar effect on fructose catabolism by the wild-type Z. mobilis CP4, and fructose uptake by Z. mobilis CP4-M2 was shown to be severely inhibited by equimolar amounts of glucose. These results suggest that competition for fructose transport plays an important role in preferential catabolism of glucose from sugar mixtures. Indeed, the apparent K(infm) values for sugar uptake by Z. mobilis CP4 were approximately 200 mM for fructose and 13 mM for glucose. Other experiments supported the conclusion that a single facilitated diffusion transport system, encoded by the glf gene, is solely responsible for the uptake of both glucose and fructose. The results are discussed with regard to the hypothesis that the kinetics of sugar transport and phosphorylation allow the preferential consumption of glucose and accumulation of fructose, making the fructose available for the enzyme glucose-fructose oxidoreductase, which forms sorbitol, an important osmoprotectant for Z. mobilis when growing in the presence of high sugar concentrations.
    Language English
    Publishing date 2006-01-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 223011-2
    ISSN 1098-5336 ; 0099-2240
    ISSN (online) 1098-5336
    ISSN 0099-2240
    DOI 10.1128/aem.63.9.3519-3525.1997
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Book ; Thesis: Molekularbiologische Untersuchungen zur Glutamataufnahme in Zymomonas mobilis und Escherichia coli

    Peekhaus, Norbert

    (Berichte des Forschungszentrums Jülich ; 3000)

    1994  

    Author's details Norbert Peekhaus
    Series title Berichte des Forschungszentrums Jülich ; 3000
    Language German
    Size 103 S, Ill., graph. Darst
    Publisher Forschungszentrum, Zentralbibliothek
    Publishing place Jülich
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Zugl.: Düsseldorf, Univ., Diss
    Database Leibniz Institute of Plant Genetics and Crop Plant Research

    More links

    Kategorien

  6. Book ; Thesis: Molekularbiologische Untersuchungen zur Glutamataufnahme in Zymomonas mobilis und Escherichia coli

    Peekhaus, Norbert

    (Berichte des Forschungszentrums Jülich ; 3000)

    1994  

    Author's details Norbert Peekhaus
    Series title Berichte des Forschungszentrums Jülich ; 3000
    Language German
    Size 103 S, Ill., graph. Darst
    Publisher Forschungszentrum, Zentralbibliothek
    Publishing place Jülich
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Univ., Diss--Düsseldorf
    Database Former special subject collection: coastal and deep sea fishing

    More links

    Kategorien

  7. Book ; Thesis: Molekularbiologische Untersuchungen zur Glutamataufnahme in Zymomonas mobilis und Escherichia coli

    Peekhaus, Norbert

    (Berichte des Forschungszentrums Jülich ; 3000)

    1994  

    Author's details Norbert Peekhaus
    Series title Berichte des Forschungszentrums Jülich ; 3000
    Language German
    Size 103 S, Ill., graph. Darst
    Publisher Forschungszentrum, Zentralbibliothek
    Publishing place Jülich
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Zugl.: Düsseldorf, Univ., Diss
    Database Library catalogue of the German National Library of Science and Technology (TIB), Hannover

    More links

    Kategorien

  8. Article: What's for dinner?: Entner-Doudoroff metabolism in Escherichia coli.

    Peekhaus, N / Conway, T

    Journal of bacteriology

    1998  Volume 180, Issue 14, Page(s) 3495–3502

    MeSH term(s) Animals ; Escherichia coli/genetics ; Escherichia coli/metabolism ; Genes, Bacterial/physiology ; Gluconates/metabolism ; Glucose/metabolism ; Hexuronic Acids/metabolism ; Humans ; Intestine, Large/microbiology ; Mammals/microbiology ; Regulon/genetics
    Chemical Substances Gluconates ; Hexuronic Acids ; Glucose (IY9XDZ35W2) ; gluconic acid (R4R8J0Q44B)
    Language English
    Publishing date 1998-07
    Publishing country United States
    Document type Journal Article ; Research Support, U.S. Gov't, Non-P.H.S. ; Review
    ZDB-ID 2968-3
    ISSN 1098-5530 ; 0021-9193
    ISSN (online) 1098-5530
    ISSN 0021-9193
    DOI 10.1128/JB.180.14.3495-3502.1998
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Positive and negative transcriptional regulation of the Escherichia coli gluconate regulon gene gntT by GntR and the cyclic AMP (cAMP)-cAMP receptor protein complex.

    Peekhaus, N / Conway, T

    Journal of bacteriology

    1998  Volume 180, Issue 7, Page(s) 1777–1785

    Abstract: The gntT gene of Escherichia coli is specifically induced by gluconate and repressed via catabolite repression. Thus, gluconate is both an inducer and a repressor of gntT expression since gluconate is a catabolite-repressing sugar. In a gntR deletion ... ...

    Abstract The gntT gene of Escherichia coli is specifically induced by gluconate and repressed via catabolite repression. Thus, gluconate is both an inducer and a repressor of gntT expression since gluconate is a catabolite-repressing sugar. In a gntR deletion mutant, the expression of a chromosomal gntT::lacZ fusion is both high and constitutive, confirming that GntR is the negative regulator of gntT. Indeed, GntR binds to two consensus gnt operator sites; one overlaps the -10 region of the gntT promoter, and the other is centered at +120 with respect to the transcriptional start site. The binding of GntR to these sites was proven in vitro by gel redardation assays and in vivo by site-directed mutagenesis of the binding sites. Binding of GntR to the operators is eliminated by gluconate and also by 6-phosphogluconate at a 10-fold-higher concentration. Interestingly, when gntR deletion strains are grown in the presence of gluconate, there is a twofold decrease in gntT expression which is independent of catabolite repression and binding of GntR to the operator sites. This novel response of gntR mutants to the inducer is termed ultrarepression. Transcription of gntT is activated by binding of the cyclic AMP (cAMP)-cAMP receptor protein (CRP) complex to a CRP binding site positioned at -71 upstream of the gntT transcription start site.
    MeSH term(s) Bacterial Proteins/genetics ; Binding Sites ; Cyclic AMP/metabolism ; Cyclic AMP/pharmacology ; DNA-Binding Proteins/genetics ; Escherichia coli/genetics ; Escherichia coli Proteins ; Genes, Bacterial ; Membrane Transport Proteins ; Mutagenesis, Site-Directed ; Promoter Regions, Genetic ; Receptors, Cyclic AMP/metabolism ; Regulon ; Repressor Proteins/genetics ; Transcription Factors ; Transcription, Genetic
    Chemical Substances Bacterial Proteins ; DNA-Binding Proteins ; Escherichia coli Proteins ; GntR protein, E coli ; Membrane Transport Proteins ; Receptors, Cyclic AMP ; Repressor Proteins ; Transcription Factors ; gluconate permease, E coli (57087-96-4) ; Cyclic AMP (E0399OZS9N)
    Language English
    Publishing date 1998-04
    Publishing country United States
    Document type Journal Article ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2968-3
    ISSN 1098-5530 ; 0021-9193
    ISSN (online) 1098-5530
    ISSN 0021-9193
    DOI 10.1128/JB.180.7.1777-1785.1998
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy.

    Bicak, Mesude / Lückerath, Katharina / Kalidindi, Teja / Phelps, Michael E / Strand, Sven-Erik / Morris, Michael J / Radu, Caius G / Damoiseaux, Robert / Peltola, Mari T / Peekhaus, Norbert / Ho, Austin / Veach, Darren / Malmborg Hager, Ann-Christin / Larson, Steven M / Lilja, Hans / McDevitt, Michael R / Klein, Robert J / Ulmert, David

    Proceedings of the National Academy of Sciences of the United States of America

    2020  Volume 117, Issue 26, Page(s) 15172–15181

    Abstract: Hu11B6 is a monoclonal antibody that internalizes in cells expressing androgen receptor (AR)-regulated prostate-specific enzyme human kallikrein-related peptidase 2 (hK2; ...

    Abstract Hu11B6 is a monoclonal antibody that internalizes in cells expressing androgen receptor (AR)-regulated prostate-specific enzyme human kallikrein-related peptidase 2 (hK2;
    MeSH term(s) Actinium/therapeutic use ; Alpha Particles ; Animals ; Biomarkers, Tumor ; Humans ; Immunoconjugates/therapeutic use ; Male ; Mice ; Mice, Nude ; Neoplasms, Experimental/therapy ; Prostate-Specific Antigen/immunology ; Prostatic Neoplasms/therapy ; Tissue Kallikreins/metabolism
    Chemical Substances Actinium-225 ; Biomarkers, Tumor ; Immunoconjugates ; Tissue Kallikreins (EC 3.4.21.35) ; Prostate-Specific Antigen (EC 3.4.21.77) ; Actinium (NIK1K0956U)
    Language English
    Publishing date 2020-06-12
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.1918744117
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top